Switching to emicizumab: A prospective surveillance study in haemophilia A subjects with inhibitors
Évemie Dubé(Institut National de la Recherche Scientifique), Georges‐Étienne Rivard(Centre Hospitalier Universitaire Sainte-Justine), Josie Pilon(Centre Hospitalier Universitaire Sainte-Justine), N. Zourikian(Centre Hospitalier Universitaire Sainte-Justine), Clémence Merlen(Centre Hospitalier Universitaire Sainte-Justine), Jean St‐Louis(Hôpital Maisonneuve-Rosemont), Julie Gauthier(Centre Hospitalier Universitaire Sainte-Justine), Arnaud Bonnefoy(Centre Hospitalier Universitaire Sainte-Justine)
Cited by 3
Related Papers
Meta-analysis of SHANK Mutations in Autism Spectrum Disorders: A Gradient of Severity in Cognitive Impairments
|PLoS Genetics|2014|672
Increased exonic de novo mutation rate in individuals with schizophrenia
|Nature Genetics|2011|448
De novo mutations in the gene encoding the synaptic scaffolding protein <i>SHANK3</i> in patients ascertained for schizophrenia
|Proceedings of the National Academy of Sciences|2010|380
Mutations in <i>SYNGAP1</i> in Autosomal Nonsyndromic Mental Retardation
|New England Journal of Medicine|2009|352
Excess of De Novo Deleterious Mutations in Genes Associated with Glutamatergic Systems in Nonsyndromic Intellectual Disability
|The American Journal of Human Genetics|2011|352